Back to search results

Observational Study of Individualized Cancer Therapy in Pancreatic Cancer

This is an observational study for people with pancreatic cancer. It aims to understand how well personalized treatments, based on the unique genetic makeup of your tumor (genomic profile), work. Researchers will look at your medical records, both past and future, to see how these targeted therapies affect your tumor, how long treatments work, your survival, and any side effects. You can join if you are at least 18 years old and have pancreatic cancer confirmed by a doctor. The study will track how many people receive targeted therapy over 5 years.

Study design
This is an observational study, meaning researchers will collect and analyze existing data rather than giving new treatments. It aims to include 1000 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will track the number of subjects receiving targeted therapy for 5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05914987

Determining Individualized Cancer Therapy in Pancreatic Cancer

Recruiting
Not specifiedAges 18+Observational
Medical College of Wisconsin
~1,000 participants
Updated 2026-05-05 on ClinicalTrials.gov
What's tested:Targeted Therapy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of Subjects Receiving Targeted Therapy
Measured over 5 years

Conditions

Pancreatic Neoplasms

Explore related trials

Pancreatic Carcinoma

Where it's being run

1 sites across 1 states
Wisconsin1

Study leadership

  • Mandana Kamgar, MD · PRINCIPAL_INVESTIGATOR · Medical College of Wisconsin

Who to contact

Cancer Center Clinical Trials Office
[email protected]
1-414-805-8900
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥18 years.
Pathologically confirmed pancreatic cancer.
Ability to understand a written informed consent document and the willingness to sign it

Exclusion

Age \<18 years.
Primary cancer diagnosis other than pancreatic cancer.

What this trial measures

  • Number of Subjects Receiving Targeted Therapy5 years

    This measure is the number of study subject's whose treating physician prescribes and subsequently receives the therapeutic recommendation of the Molecular Tumor Board.